Mutations in the genes encoding for isocitrate dehydrogenase (IDH) have been discovered in various cancers such as glioma, acute myeloid leukemia (AML), chondrosarcoma, cholangiocarcinoma, paraganglioma, colon cancer, prostate cancer and lung cancer [2]. Here, IDH2 is linked to acute myeloid leukemia.